Pfizer CEO focused on producing ‘as many doses as possible’ following full FDA approval
Albert Bourla, chairman and CEO of Pfizer, said on ‘America’s Newsroom’ that current demand for his coronavirus vaccine is ‘significantly’ higher than the supply and that the company is ‘working to resolve’ the issue.